THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2018

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2018

WEBINARS

Register Now and
On Demand

Home » Archive by Tags

Articles tagged with: Roche

Roche showcases new test options at ASM Microbe

June 8, 2018—Roche will feature at ASM Microbe 2018, in Atlanta, new test options that aim to expand the opportunities …

Roche to acquire Ignyta, 4/18

April 2018—Roche will acquire San Diego–based Ignyta for $27.00 per share in cash, or $1.7 billion. Ignyta, which will continue its operations in San Diego, focuses on precision medicine in oncology aiming to test, identify, and treat patients with cancers harboring specific rare mutations.

CE-marked Cobas Plasma Separation Card, 4/18

April 2018—Roche launched the Cobas Plasma Separation Card, a sample collection device for HIV plasma viral load testing. By requiring only a small amount of a patient’s blood from a fingertip, this card simplifies blood collection and sample transportation, as compared with traditional plasma-based testing.

Roche, GE to develop digital diagnostics platform, 4/18

April 2018—Roche and GE Healthcare will partner to develop and co-market digital clinical decision support solutions. The companies aim to develop a digital platform using analytics to provide workflow solutions and apps that support clinical decisions. This will allow the integration and analysis of in vivo and in vitro data, patient records, medical best practices, real-time monitoring, and the latest research outcomes.

Discovery Teal HRP chromogen detection kit, 3/18

March 2018—Roche launched the Discovery Teal HRP kit, a modular-based detection kit to identify and profile biomarkers and cell populations in tissue-based research.

FDA approves Roche’s alectinib product

Nov. 27, 2017—Roche announced that the FDA approved the supplemental new drug application for Alecensa (alectinib) for the treatment of …

Roche to acquire Viewics

Nov. 20, 2017—Roche announced today it will acquire Viewics, a privately held software company focused on laboratory business analytics. This …

FDA clears Roche panel for colorectal cancer

Nov. 14, 2017—Roche announced today FDA clearance of the Ventana MMR IHC Panel, which provides clinicians with a group of …

Roche gains CE mark for expanded use of PD-L1 assay,11/17

November 2017—Roche announced the expanded use of the Ventana PD-L1 (SP142) Assay in non-small cell lung cancer and metastatic urothelial carcinoma in CE markets in which the Roche cancer immunotherapy medicine Tecentriq is approved.

Roche to initiate testing for babesia parasite

Oct. 6, 2017—Roche announced immediate plans to initiate screening of blood samples with the Cobas Babesia test under an FDA …

X